Enabling homes to realise zero pollution holds multiple health benefits for all Europeans – especially our children. This is the goal of the EU-funded INQUIRE project. It will provide the knowledge, tools and measures needed to significantly enhance indoor air quality. Research on hazardous determinants and their sources, risk factors and effects will focus in particular on infants and young children up to 5 years old. The work will include non-invasive sampling and monitoring of over 200 homes in eight countries over the course of 1 month. Results will inform evidence-based recommendations and support beneficial exploitation by industry and policymakers.
The first IDEAL Cluster policy brief is out – check it out!
Are you interested in air quality research?
Join our workshop and learn how we use real-life air pollutants for in vitro toxicological assessment!
This week on 9-10 Sept. 2024, the third in-person INQUIRE consortium meeting will be taking place with project partners in Cambridge, UK
Have you been informed about the IDEAL Cluster's first policy brief?
👉The first Joint Policy Brief (JPB1) of the #IDEAL Cluster provides a comprehensive overview of the current state of Indoor Air Quality in Europe.
🔗 https://bit.ly/49iDk6r
#HorizonEurope #IAQ #EUresearch
📢Check out the next webinar from @ediaqi_project
🔔Save the date to learn more about low-cost #sensors and #IndoorAirQuality management
#IAQ @INQUIRE_EU @IDEAL_CLUSTER
📢Do you want to find out more about our partner project @LearnProjectHeu in the @IDEAL_CLUSTER ⁉️
Check out their Linktree below 😀
This work was co-funded by UK Research and Innovation (UKRI) under the UK government’s Horizon Europe funding guarantee [grant number 10038689 and 10042425].
Co-funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Health and Digital Executive Agency (HaDEA). Neither the European Union nor the granting authority can be held responsible for them.
The work received funding support from the Australian National Health and Medical Research Council (NHMRC) [NHMRC; 2022/GNT2017837].